Cognitive Impairment in Drug-Resistant Epilepsy: A Multidomain Systematic Review
Brain Sciences · 13.10.2026 · 16 (10) · 1103
DOI: 10.3390/brainsci16101103 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain Sciences, erschienen am 13.10.2026. Verfasst von Mateusz Bargielski und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Clinical Hospital in Białystok, 24A Marii Skłodowskiej-Curie Street, 15-276 Białystok, Poland. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Drug-resistant epilepsy (DRE) is frequently accompanied by cognitive impairment across multiple neuropsychological domains.
Objectives
We aimed to synthesize contemporary evidence on cognitive impairment, neurobiological correlates, potentially modifiable clinical factors, and treatment-related cognitive outcomes in predominantly adult populations with DRE.
Methods
PubMed/MEDLINE and Web of Science were searched for studies published between January 2017 and September 2026, supplemented by citation searching. Twenty-two studies comprising 2359 participants were included, of whom 1616 (68.5%) had confirmed DRE. Eligibility was independently verified by a second reviewer, and risk of bias was assessed independently by two reviewers using design-specific Joanna Briggs Institute tools. Owing to substantial clinical and methodological heterogeneity, a structured qualitative synthesis was performed.
Results
Cognitive impairment involved memory, executive function, attention, language, and processing- or psychomotor-speed-related performance. Cognitive performance was associated with distributed neurobiological abnormalities and with clinical factors including sleep quality, antiseizure medication exposure, and seizure burden. Treatment- and surgery-related cognitive outcomes varied across studies. The predominantly observational evidence and substantial heterogeneity limited causal inference.
Conclusions
Cognitive impairment in DRE is heterogeneous and extends beyond memory dysfunction. Current evidence supports multidomain neuropsychological assessment and is compatible with a distributed network framework, although causal mechanisms remain uncertain.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, University Clinical Hospital in Białystok, 24A Marii Skłodowskiej-Curie Street, 15-276 Białystok, Poland.
- Department of Clinical Research Support, Medical University of Białystok, 17 Jerzego Waszyngtona Street, 15-369 Białystok, Poland.
- Department of Endocrinology, University Clinical Hospital in Białystok, 24A Marii Skłodowskiej-Curie Street, 15-276 Białystok, Poland.
ORCID-Profile: Mateusz Bargielski, Edyta Adamska-Patruno
Zitieren
APA
Bargielski, M., Adamska-Patruno, E., Krętowski, A., Kochanowicz, J., Kułakowska, A., & Chorąży, M. (2026). Cognitive Impairment in Drug-Resistant Epilepsy: A Multidomain Systematic Review. Brain Sciences. https://doi.org/10.3390/brainsci16101103
Vancouver
Bargielski M, Adamska-Patruno E, Krętowski A, Kochanowicz J, Kułakowska A, Chorąży M. Cognitive Impairment in Drug-Resistant Epilepsy: A Multidomain Systematic Review. Brain Sciences. 2026. doi:10.3390/brainsci16101103
BibTeX
@article{Bargielski2026,
author = {Bargielski, Mateusz and Adamska-Patruno, Edyta and Krętowski, Adam and Kochanowicz, Jan and Kułakowska, Alina and Chorąży, Monika},
title = {Cognitive Impairment in Drug-Resistant Epilepsy: A Multidomain Systematic Review},
journal = {Brain Sciences},
year = {2026},
doi = {10.3390/brainsci16101103}
}
EUVIMED